SPOTLIGHT: Daiichi Sankyo buys OTC business
Daiichi Sankyo has inked a deal to buy the OTC unit of Astellas--Zepharma--for 20 billion yen. Report
Published on FierceBiotech (http://www.fiercebiotech.com)
Published on FierceBiotech (http://www.fiercebiotech.com)
Daiichi Sankyo has inked a deal to buy the OTC unit of Astellas--Zepharma--for 20 billion yen. Report